Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multi-institutional randomized phase III study comparing minimally invasive distal pancreatectomy versus open distal pancreatectomy for pancreatic cancer; Japan Clinical Oncology Group study JCOG2202 (LAPAN study).
Ikenaga N, Hashimoto T, Mizusawa J, Kitabayashi R, Sano Y, Fukuda H, Nakata K, Shibuya K, Kitahata Y, Takada M, Kamei K, Kurahara H, Ban D, Kobayashi S, Nagano H, Imamura H, Unno M, Takahashi A, Yagi S, Wada H, Shirakawa H, Yamamoto N, Hirono S, Gotohda N, Hatano E, Nakamura M, Ueno M; on behalf of the Hepatobiliary and Pancreatic Oncology Group in Japan Clinical Oncology Group. Ikenaga N, et al. Among authors: kurahara h. BMC Cancer. 2024 Feb 19;24(1):231. doi: 10.1186/s12885-024-11957-9. BMC Cancer. 2024. PMID: 38373949 Free PMC article. Clinical Trial.
Significance of neoadjuvant therapy for borderline resectable pancreatic cancer: a multicenter retrospective study.
Kurahara H, Shinchi H, Ohtsuka T, Miyasaka Y, Matsunaga T, Noshiro H, Adachi T, Eguchi S, Imamura N, Nanashima A, Sakamoto K, Nagano H, Ohta M, Inomata M, Chikamoto A, Baba H, Watanabe Y, Nishihara K, Yasunaga M, Okuda K, Natsugoe S, Nakamura M. Kurahara H, et al. Langenbecks Arch Surg. 2019 Mar;404(2):167-174. doi: 10.1007/s00423-019-01754-5. Epub 2019 Jan 16. Langenbecks Arch Surg. 2019. PMID: 30649607
[No title available]
[No authors listed] [No authors listed] PMID: 36171527
A Prospective Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer with Arterial Involvement.
Ikenaga N, Miyasaka Y, Ohtsuka T, Nakata K, Adachi T, Eguchi S, Nishihara K, Inomata M, Kurahara H, Hisaka T, Baba H, Nagano H, Ueki T, Noshiro H, Tokunaga S, Ishigami K, Nakamura M; Kyushu Study Group of Treatment for Pancreatobiliary Cancer. Ikenaga N, et al. Among authors: kurahara h. Ann Surg Oncol. 2023 Jan;30(1):193-202. doi: 10.1245/s10434-022-12566-1. Epub 2022 Oct 7. Ann Surg Oncol. 2023. PMID: 36207481 Clinical Trial.
Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis.
Okusaka T, Nakamura M, Yoshida M, Kitano M, Ito Y, Mizuno N, Hanada K, Ozaka M, Morizane C, Takeyama Y; Committee for Revision of Clinical Guidelines for Pancreatic Cancer of the Japan Pancreas Society. Okusaka T, et al. Int J Clin Oncol. 2023 Apr;28(4):493-511. doi: 10.1007/s10147-023-02317-x. Epub 2023 Mar 15. Int J Clin Oncol. 2023. PMID: 36920680 Free PMC article.
Prognostic significance of lymph node metastasis in pancreatic tail cancer: A multicenter retrospective study.
Hirashita T, Ikenaga N, Nakata K, Nakamura M, Kurahara H, Ohtsuka T, Tatsuguchi T, Nishihara K, Hayashi H, Nakagawa S, Ide T, Noshiro H, Adachi T, Eguchi S, Miyoshi A, Kohi S, Nanashima A, Nagano H, Takatsuki M, Inomata M; Kyushu Study Group of Treatment for Pancreatobiliary Cancer. Hirashita T, et al. Among authors: kurahara h. Ann Gastroenterol Surg. 2024 Jan 9;8(4):681-690. doi: 10.1002/ags3.12771. eCollection 2024 Jul. Ann Gastroenterol Surg. 2024. PMID: 38957555 Free PMC article.
Optimal treatment strategy for patients with pancreatic cancer having positive peritoneal cytology: A nationwide multicenter retrospective cohort study supervised by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Ariake K, Mizuma M, Unno M, Satoi S, Yamamoto N, Hayashi M, Kawai M, Akita H, Toyoda E, Fujii T, Sasaki M, Hakamada K, Watanabe J, Hatano E, Hidaka M, Hirano S, Kurahara H, Matsumoto I, Honda G, Ogura T, Nakamura M, Endo I. Ariake K, et al. Among authors: kurahara h. J Hepatobiliary Pancreat Sci. 2024 Sep 24. doi: 10.1002/jhbp.12074. Online ahead of print. J Hepatobiliary Pancreat Sci. 2024. PMID: 39317950
[Clinical usefulness of FDG-PET for pancreatic cancer].
Mataki Y, Shinchi H, Kurahara H, Maemura K, Noma H, Natsugoe S, Takao S. Mataki Y, et al. Among authors: kurahara h. Gan To Kagaku Ryoho. 2009 Dec;36(13):2516-20. Gan To Kagaku Ryoho. 2009. PMID: 20009449 Japanese.
Prognostic impact of CD168 expression in gastric cancer.
Ishigami S, Ueno S, Nishizono Y, Matsumoto M, Kurahara H, Arigami T, Uchikado Y, Setoyama T, Arima H, Yoshiaki K, Kijima Y, Kitazono M, Natsugoe S. Ishigami S, et al. Among authors: kurahara h. BMC Cancer. 2011 Mar 24;11:106. doi: 10.1186/1471-2407-11-106. BMC Cancer. 2011. PMID: 21435222 Free PMC article.
208 results